Choose the Right Multimodal Data Platform in 2025: Evaluation Essentials for Science and Data Teams

As you plan and budget for 2025, is large-scale multimodal data taking center stage? Do you have the right technology in place to prosecute this work effectively and efficiently across researchers, informatics and ML teams? How will you prioritize a FAIR multi-omics platform? If the answer is no, or I’m not sure, you’re not alone. The status quo infrastructure map for -omics data is complex and still emerging. How should you evaluate technology that will serve your goals today and into the future? In this session, learn key evaluation criteria to help inform durable decisions for your data platform to drive drug discovery and development.